Strategic Blueprint’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-460
| Closed | -$200K | – | 685 |
|
|
2025
Q1 | $200K | Buy |
+460
| New | +$200K | 0.01% | 655 |
|
|
2024
Q4 | – | Sell |
-560
| Closed | -$291K | – | 657 |
|
|
2024
Q3 | $291K | Buy |
560
+18
| +3% | +$9.37K | 0.02% | 518 |
|
|
2024
Q2 | $294K | Buy |
542
+32
| +6% | +$17.3K | 0.02% | 498 |
|
|
2024
Q1 | $264K | Sell |
510
-91
| -15% | -$47.2K | 0.02% | 518 |
|
|
2023
Q4 | $283K | Sell |
601
-5
| -0.8% | -$2.36K | 0.02% | 471 |
|
|
2023
Q3 | $264K | Sell |
606
-29
| -5% | -$12.6K | 0.02% | 449 |
|
|
2023
Q2 | $282K | Sell |
635
-75
| -11% | -$33.3K | 0.03% | 439 |
|
|
2023
Q1 | $327K | Sell |
710
-90
| -11% | -$41.4K | 0.03% | 388 |
|
|
2022
Q4 | $411K | Buy |
800
+6
| +0.8% | +$3.08K | 0.05% | 333 |
|
|
2022
Q3 | $361K | Sell |
794
-74
| -9% | -$33.6K | 0.04% | 327 |
|
|
2022
Q2 | $419K | Buy |
868
+4
| +0.5% | +$1.93K | 0.05% | 305 |
|
|
2022
Q1 | $424K | Sell |
864
-16
| -2% | -$7.85K | 0.05% | 311 |
|
|
2021
Q4 | $408K | Sell |
880
-45
| -5% | -$20.9K | 0.05% | 309 |
|
|
2021
Q3 | $345K | Buy |
925
+526
| +132% | +$196K | 0.05% | 297 |
|
|
2021
Q2 | $152K | Buy |
+399
| New | +$152K | 0.02% | 404 |
|
|
2019
Q4 | – | Sell |
-304
| Closed | -$73K | – | 184 |
|
|
2019
Q3 | $73K | Buy |
+304
| New | +$73K | 0.06% | 126 |
|